Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K221900
    Date Cleared
    2023-09-29

    (456 days)

    Regulation Number
    862.1120
    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Stat Profile Prime Plus Analyzer System is indicated for use by healthcare professionals in clinical laboratory settings and for point-of-care usage for quantitative determination of pH, Partial Pressure of Carbon Dioxide (pCO2), Partial Pressure of Oxygen (pO2), Hematocrit, Sodium, Chloride, Ionized Calcium, Ionized Magnesium, Gucose, and Lactate in heparinized capillary whole blood.

    Indication for Use: pH, pCO2, pO2 measurements are used in the diagnosis and treatment of life-threatening acid base disturbances.

    Hematocrit (Hct) measurements of the packed red blood cell volume are used to distinguish normal states, such as anemia and erythrocytosis.

    Glucose (Glu) measurement is used in the diagnosis and treatment of carbohydrate metabolism distuding diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

    Lactate (lactic acid) measurement is used to evaluate the acid-base status of patients suspected of having lactic acidosis.

    Sodium (Na) measurements are used in the diagnosis and treatment of aldosteronism, diabetes insipidus, adrenal hypertension, Addison's disease, dehydration, or diseases involving electrolyte imbalance.

    Potassium (K) measurements are used in the diagnosis and treatment of disease conditions characterized by low or high potassium levels.

    Chloride (Cl) measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

    Ionized Calcium (iCa) measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

    Ionized Magnesium (iMg) measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low levels of magnesium) and hypermagnesemia (abnormally high levels of magnesium).

    Device Description

    The Stat Profile Prime Plus Analyzer System is an analyzer for use in hospital laboratory and point-of-care settings. It consists of the analyzer, sensor cartridges, and thermal paper for an onboard printer. Optionally, it provides for reading of barcode labels (such as operator badges and data sheets).

    The Stat Profile Prime Plus Analyzer has slots to accommodate two sensor cartridges (Primary and Auxiliary). The analyzer will determine the configuration of the system by detecting which sensor cards are installed.

    Primary Sensor Card Port:
    There are two options for the primary sensor card:

    • Primary Sensor Card 1 shall enable and report the following listed analytes: .
      • PO2, PCO2, pH, Hct, tHb, SO2, O2Hb, COHb, MetHb, HHb, Glu, Lactate, Sodium, o Potassium, Chloride, Calcium, Ionized Magnesium
    • Primary Sensor Card 2 shall enable and report the following listed analytes: .
      • PO2, PCO2, pH, Hct, tHb, SO2, Glu, Lactate, Sodium, Chloride, Calcium, Ionized o Magnesium

    Auxiliarv Sensor Card Port:
    The reporting of Creatinine and BUN parameters (or not reporting them) shall be determined by the selection of the Auxiliary Sensor Card

    • . Auxiliary Sensor Card 1 shall enable the Creatinine and BUN parameters
    • Auxiliary Sensor Card 2 shall be a "dummy" sensor card and will not report any parameters. .

    As with the predicate, the Stat Profile Prime Plus Analyzer is a blood gas, co-oximetry, electrolyte, chemistry, and hematology analyzer with an enhanced test menu and multiple quality control options. Both traditional internal and external quality control is available, as well as an on-board Quality Management System (QMS), and an electronic monitoring approach that ensures the analyzer is working properly.

    The Stat Profile Prime Plus Analyzer accepts samples from syringes, open tubes, and capillary tubes. The sample size for analysis is 135 µL for the complete test panel or 90 µL for the capillary panel.

    Sample collection, preparation and application to the analyzer are the same as for the previously cleared predicate. The end user can select which analytes are to be tested in the panel.

    Stat Profile Prime Plus Analyzer System Components:
    The Stat Profile Prime Plus Analyzer System is comprised of the following components.

    • . Stat Profile Prime Plus Analyzer System
    • Primary Sensor Cartridge .
    • Auxiliary Sensor Cartridge .
    • Stat Profile Prime Plus Auto-Cartridge Quality Control Pack
    • Stat Profile Prime Plus Calibrator Cartridge
    • Stat Profile Prime Plus External Ampule Control
    • . IFU/Labeling

    Sample Types:
    The Stat Profile Prime Plus Analyzer System accepts lithium heparinized arterial, venous, and capillary whole blood.

    Measured Parameters:
    The Stat Profile Prime Plus Analyzer measures:

    • . pH
    • . Partial Pressure of Carbon Dioxide (pCO2)
    • Partial Pressure of Oxygen (pO2) ●
    • Hematocrit (Hct) ●
    • . Glucose (Glu)
    • . Lactate (Lac)
    • Sodium (Na) ●
    • Potassium (K)
    • Chloride (CI)
    • . Ionized Calcium (iCa)
    • . lonized Magnesium (iMg)
    AI/ML Overview

    The Nova Biomedical Stat Profile Prime Plus Analyzer System is undergoing a 510(k) premarket notification to expand its indications for use to include capillary whole blood specimen testing for pH, pCO2, pO2, Sodium (Na+), Potassium (K+), Chloride (Cl-), Ionized Calcium (Ca2+), Ionized Magnesium (Mg2+), Glucose, Lactate, and Hematocrit. The study described focuses on demonstrating the substantial equivalence of the Stat Profile Prime Plus Analyzer system to its predicate device, the Nova Biomedical Stat Profile pHOx Ultra Analyzer, specifically for capillary whole blood samples.

    Here's an analysis of the acceptance criteria and the study that proves the device meets them:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria for substantial equivalence are primarily demonstrated through method comparison and precision studies. While explicit numerical acceptance criteria for each parameter (e.g., specific ranges for slope, intercept, r-value in method comparison, or max SD/CV% for precision) are not directly stated in the provided text as a standalone table, the conclusion sections for each study indicate that the device "met the clinical accuracy acceptance criteria" or "met the performance criteria for precision." The reported performance is shown in the tables below, which are the primary evidence for meeting the implicit acceptance criteria.

    Method Comparison (Clinical Accuracy - Comparison to Predicate Device)

    ParameterN (Combined)Altered Samples (Combined)Whole Blood Range (Combined)SlopeInterceptr
    pH249186.790-7.7290.98940.07360.9942
    pO2, (mmHg)251207.5-567.11.00060.83200.9976
    pCO2, (mmHg)245147.4-183.11.0075-0.59690.9968
    Hct, (%)2411018-550.99000.80110.9876
    Na, (mM)2431283.0-195.61.0129-2.22440.9885
    K, (mM)245141.34-18.530.99400.04160.9987
    Cl, (mM)2431264.5-191.60.99440.34940.9856
    Ca, (mM)247160.37-2.460.99000.01550.9932
    Mg, (mM)249180.13-1.220.96590.02140.9811
    Glu, (mg/dL)2451428-4520.99500.90410.9969
    Lac, (mM)243120.4-17.61.00010.01190.9989

    Precision (Laboratory and Point-of-Care Settings)

    The precision data is presented across multiple tables (Tables 4, 5, 6, 7, 8, 9, 10). Rather than reiterating all data here, the text explicitly states:

    • "The precision data for all samples in capillary mode met the within run and between analyzer imprecision specifications for the Prime Plus analyzers." (Summary of Capillary Mode Within Sample Precision)
    • "This study demonstrates the Stat Profile Prime Plus analyzer exhibits clinically acceptable imprecision specifications for pH, pCO2, pO2, sodium (Na+), chloride (C1-), potassium (K+), ionized calcium (Ca2+), ionized magnesium (Mg2+), glucose, lactate, and hematocrit measured by the Stat Profile Prime Plus Analyzer System in Capillary mode." (Conclusion of Within-Run Imprecision - Capillary Mode Fingerstick (External POC))
    • "The analyzer used for this evaluation met the performance criteria for within sample precision on capillary fingerstick specimens run by POC operators." (Conclusion of Within-Sample Imprecision - Capillary Mode Fingerstick (Internal POC))
    • "The Stat Profile Prime Plus analyzers provided consistently reliable performance throughout the evaluation study. The analyzers used for this evaluation met the acceptance criteria for precision." (Conclusion of Within-Run Imprecision - Capillary Mode)

    The acceptance criteria are therefore implicitly met by the reported r-values nearing 1.0 and slopes nearing 1.0 with intercepts near 0 for method comparison, and the CV% and SD values falling within acceptable limits (though the limits themselves are not numerically specified in the provided text).

    2. Sample Sizes Used for the Test Set and Data Provenance

    • Method Comparison Test Set (Capillary Mode):

      • For each measured parameter, the sample size (N) ranged from 118 to 123 at the ER site and 123 to 128 at the Hemodialysis site. The combined sample size (N) for each parameter ranged from 241 to 251.
      • Provenance: This was a prospective clinical study conducted at two external Point-of-Care (POC) sites within the United States (an Emergency Room and a Hemodialysis Unit). Some samples (less than 10%, indicating "Altered Samples" ranging from 5 to 10 for each site) were altered to cover the full dynamic range. These were "de-identified and discarded arterial blood specimens" for the external precision study (implicitly reflecting human samples, though the exact origin beyond "external POC site" is not specified beyond being collected from patients).
    • Precision Test Set (Capillary Mode):

      • Within Run Precision (Internal Lab): 20 replicates for each parameter, tested on two Prime Plus analyzers from venous blood transferred to capillary tubes. This appears to be lab-based, controlled samples.
      • Within Sample Precision (Internal Lab): 2 replicates from 30 different donors (Total N=60 for each analyte) of capillary whole blood. This implies human subjects.
      • Within-Run Imprecision (External POC): Sample analysis involved transferring discarded arterial blood specimens from a lithium heparin syringe to three balanced heparin capillary tubes. The number of unique discarded specimens is not explicitly stated but "each whole blood specimen" suggests multiple, distinct specimens were used.
      • Within-Sample Imprecision (Internal POC - Fingerstick): Capillary whole blood was collected via fingerstick puncture from individuals, with 2 replicates for each. N=60 for all sample pairs. This explicitly involves human subjects/donors.
      • Within-Run Imprecision (Internal Study - Lab): 5 different concentrations of deidentified venous whole blood specimens per analyte. Each concentration was run on 3 Prime Plus analyzers, 5 days, 1 run/day, 8 replicates/run/level. This totals 120 (5 concentrations * 3 analyzers * 5 days * 8 replicates) data points per analyte for the "N" value in Table 10. These are likely controlled lab samples simulating human blood.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    The provided text does not explicitly state the number of experts used or their specific qualifications for establishing ground truth.

    • For the method comparison study, the predicate device (Nova Stat Profile pHOx Ultra Analyzer) serves as the "ground truth" or reference method for comparison. The performance of this predicate device itself is assumed to be established and accepted.
    • For the precision studies, the intrinsic analytical performance of the device is assessed, rather than against a human expert's interpretation.

    4. Adjudication Method for the Test Set

    This information is not applicable as the device measures objective chemical and physical parameters rather than interpreting images or clinical signs that would require human adjudication. The "ground truth" is the measurement from the predicate device or the inherent value in the sample for precision studies.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, Effect Size

    This information is not applicable as the device is an in-vitro diagnostic (IVD) analyzer for quantitative measurements, not an AI imaging or diagnostic algorithm requiring human reader performance studies. The study focuses on instrument performance and equivalence rather than human reader improvement with AI assistance.

    6. If a Standalone (Algorithm Only Without Human-in-the Loop Performance) Was Done

    Yes, the studies conducted (method comparison and precision) are standalone performance evaluations of the device's accuracy and precision in measuring the analytes. There is no "human-in-the-loop" aspect to the analytical performance being evaluated; the device provides direct quantitative measurements.

    7. The Type of Ground Truth Used

    • Method Comparison: The "ground truth" or reference standard for comparison was the predicate device, the Nova Stat Profile pHOx Ultra Analyzer. This is a comparative method where the new device's performance is assessed against an already legally marketed and accepted device.
    • Precision Studies: The "ground truth" for precision is the measured value itself and its statistical variation across multiple runs or samples. It's an assessment of the device's inherent reproducibility and repeatability, not against an external truth source like pathology or outcomes data. Human samples (venous and capillary whole blood) were used to test performance under realistic conditions.

    8. The Sample Size for the Training Set

    The provided text does not mention a training set as this is not a machine learning or AI-driven device in the sense of requiring an explicit training phase with labeled data in the way an imaging algorithm would. This is an analytical instrument based on established sensor technology and algorithms. Therefore, discussions of training sets and their sample sizes are typically not relevant for this type of device submission. The device uses "the same sensor technology, measurement algorithms, formulations of the internal and external controls, and calibrator cartridge" as its predicate, implying a well-established design.

    9. How the Ground Truth for the Training Set Was Established

    As no training set is discussed or implied to be applicable for this type of analytical device in the provided context, this question is not applicable.

    Ask a Question

    Ask a specific question about this device

    K Number
    K200204
    Date Cleared
    2020-04-06

    (69 days)

    Product Code
    Regulation Number
    864.7500
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K180186

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Stat Profile® Prime Plus Analyzer System is indicated for use by healthcare professionals in clinical laboratory settings and for point-of-care usage for quantitative determination of Hematocrit, Oxygen Saturation, Total Hemoglobin, Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin, and Deoxyhemoglobin in heparinized arterial and venous whole blood.

    Device Description

    The Stat Profile Prime Plus Analyzer System is a low cost, low maintenance analyzer for hospital laboratory and point-of-care settings. It consists of the analyzer, sensor cartridges, and thermal paper for an onboard printer. Optionally, it provides for reading of barcode labels (such as operator badges and data sheets).

    The Stat Profile Prime Plus Analyzer has slots to accommodate two sensor cartridges (Primary and Auxiliary). The analyzer will determine the configuration of the system by detecting which sensor cards are installed.

    As with the predicate, the Stat Profile Prime Plus Analyzer is a blood gas, co-oximetry, electrolyte, chemistry, and hematology analyzer with an enhanced test menu and multiple quality control options. Both traditional internal and external quality control is available, as well as an on-board Quality Management System (QMS), and an electronic monitoring approach that insures the analyzer is working properly at all times.

    The Stat Profile Prime Plus Analyzer accepts samples from syringes and open tubes. The minimum sample size for analysis is 135 µL.

    Sample collection, preparation and application to the analyzer are the same as for the previously cleared predicate. The end user can select which analytes are to be tested in the panel.

    AI/ML Overview

    The provided text describes the performance validation of the Stat Profile® Prime Plus Analyzer System, specifically focusing on its point-of-care (POC) capabilities and comparability to a predicate device. This is a medical device, not an AI/ML software. Therefore, many of the requested categories related to AI/ML software development (e.g., number of experts for ground truth, adjudication method, MRMC studies, training set details) are not applicable to this document.

    However, I can extract information related to the device's acceptance criteria and how its performance was proven.

    Here's the breakdown of the available information:

    Acceptance Criteria and Reported Device Performance

    The acceptance criteria are implicitly defined by demonstrating "substantial equivalence" to the predicate device and by meeting established criteria for method comparison and imprecision, based on CLSI guidelines. The performance data is presented as method comparison statistics (slope, intercept, r-value) and total imprecision (SD, %CV).

    Table of Acceptance Criteria and Reported Device Performance

    The document doesn't explicitly state quantitative acceptance criteria thresholds for each parameter prior to the results. Instead, it presents the quantitative results from the study and concludes that these results "confirmed that the performance of the Stat Profile Prime Plus Analyzer System is substantially equivalent to that of the Nova Stat Profile pHOx Ultra Analyzer System (predicate device)."

    Therefore, I will present the reported device performance, and the implicit acceptance can be inferred as meeting industry standards for substantial equivalence in medical devices of this type.

    AnalyteN (samples)Range (tested)SlopeInterceptr (correlation coefficient)MDL (Min. Detection Limit)95% Confidence Interval of Bias (Lower-Upper)Total Imprecision (Representative Data)
    Hct41718 - 690.99970.13150.992920-5620-20Level 1: Mean 61, Total %CV 0.9
    Level 2: Mean 38, Total %CV 0.8
    Level 3: Mean 27, Total %CV 1.6
    SO239830 - 1001.0084-0.96640.998280-9080-80Level 1: Mean 47.5, Total %CV 1.4
    Level 2: Mean 78.0, Total %CV 0.5
    Level 3: Mean 91.0, Total %CV 0.0
    tHb4165.0 - 24.21.0042-0.00580.99237-226.9-7.1Level 1: Mean 19.8, Total %CV 1.0
    Level 2: Mean 13.3, Total %CV 2.2
    Level 3: Mean 6.6, Total %CV 2.2
    O2Hb4227.1 - 98.41.0072-0.86360.998385-9084.6-85.1Level 1: Mean 20.5, Total %CV 1.7
    Level 2: Mean 47.1, Total %CV 0.9
    Level 3: Mean 80.1, Total %CV 0.2
    COHb4250.3 - 50.51.0024-0.00130.99863-103.0-3.0Level 1: Mean 29.2, Total %CV 0.7
    Level 2: Mean 21.2, Total %CV 1.4
    Level 3: Mean 6.2, Total %CV 1.5
    MetHb4370.3 - 56.71.00400.00060.99935-105.0-5.0Level 1: Mean 27.7, Total %CV 0.4
    Level 2: Mean 18.4, Total %CV 1.2
    Level 3: Mean 5.8, Total %CV 2.3
    HHb3220.4 - 39.71.01230.08820.99626-156.0-6.3Level 1: Mean 22.7, Total %CV 0.6
    Level 2: Mean 13.2, Total %CV 1.2
    Level 3: Mean 7.9, Total %CV 1.7

    2. Sample Size and Data Provenance

    • Test Set Sample Size:
      • Method Comparison (POC vs. Lab):
        • Hct: 417 samples
        • SO2: 398 samples
        • tHb: 416 samples
        • O2Hb: 422 samples
        • COHb: 425 samples
        • MetHb: 437 samples
        • HHb: 322 samples
      • Total Imprecision Performance: 20 runs performed on 3 analyzers, using 3 levels of quality control/linearity materials.
      • Within-Run Whole Blood Precision: Minimum of 2 operators per site across 3 POC sites (total 9 operators). Each precision run consisted of 10 replicate measurements using 7 different whole blood samples (5 native, 2 altered).
    • Data Provenance: The study was conducted in the United States, across three Point-of-Care (POC) sites: a Cardiothoracic Intensive Care Unit (CTICU), an Emergency Department (ED), and a Respiratory Therapy Lab (RT). The data utilized a mix of quality control materials and discarded blood gas specimens. This suggests prospective collection of real-world samples within a clinical setting.

    3. Number of Experts and Qualifications for Ground Truth

    • This device is a medical diagnostic instrument, not an AI/ML algorithm. Ground truth for the method comparison study was established by laboratory measurements (presumably using the established predicate device or a gold standard lab method) which the new device's results were compared against.
    • The study involved "trained Healthcare Professionals" and "POC personnel". These personnel performed the tests on the new device. Their qualifications are described as "trained, qualified staff found in typical POC sites where blood gas analyzers are utilized," including Respiratory Care, Nursing, and Exercise Physiology personnel. No "experts" in the sense of adjudicating image interpretations are mentioned, as this is not an imaging AI.

    4. Adjudication Method for the Test Set

    • Not applicable. This is a quantitative measurement device, not an interpretive one requiring expert adjudication. The comparison was quantitative against a reference method.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • Not applicable. This is a quantitative measurement device, not an AI-assisted diagnostic tool that would be evaluated for human reader improvement. The study compares the new device's performance to a predicate device and laboratory methods.

    6. Standalone Performance

    • Yes, effectively. The "Stat Profile® Prime Plus Analyzer System" provides quantitative measurements. The performance data presented (Method Comparison, Total Imprecision, Within-Run Whole Blood Precision) represents the standalone performance of the device in generating these measurements, compared against established laboratory methods or statistical precision targets. There is no "human-in-the-loop" performance as the human simply operates the device to obtain the measurement.

    7. Type of Ground Truth Used

    • Comparative ("Reference") Method: For the method comparison study, the ground truth was the results obtained from analyses performed by "Lab" (laboratory reference methods, presumably the predicate device or another validated laboratory analyzer). This is a comparative ground truth against an established standard.
    • Statistical Targets: For precision studies, the ground truth is implicitly defined by the acceptable statistical variance and bias from the mean of repeated measurements, often against known control material values.

    8. Sample Size for the Training Set

    • Not applicable. This is a physical, chemical, and optical measurement device, not a machine learning model that requires a "training set" in the computational sense. The device's measurement algorithms are fixed based on spectrophotometric and impedance principles.

    9. How the Ground Truth for the Training Set was Established

    • Not applicable, as there is no "training set" for an AI/ML model for this device. The principles of measurement are based on established scientific methods (e.g., spectrophotometry and impedance) and not trained on data in the AI/ML sense.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1